Introduction: The burden of pneumococcal disease in older UK adults remains substantial. Higher valency pneumococcal conjugate vaccines (PCVs) are currently in development with adult formulations for two of these anticipated to become available in 2022. This article collates and reviews relevant candidate data now available that may be used to support cost effectiveness assessments of vaccinating immunocompetent UK adults aged ≥65-years with PCVs.
Areas Covered: This article uses published data from surveillance systems, randomized controlled trials and observational studies. It focuses on local data from the UK but where these are either limited or not available relevant global data are considered.
Expert Opinion: The body of relevant data now available suggests the UK is well placed to assess the cost effectiveness of vaccinating immunocompetent ≥65-year olds with new generation higher valency PCVs. Recent contemporary data provide important new and robust insights into the epidemiology of pneumococcal disease in older UK adults and help to address much of the uncertainty and data gaps associated with previous analyses. Using these data to make informed decisions about use of new higher valency PCVs for routine use in older adults will be important for public health in the UK.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1080/14760584.2021.1984888 | DOI Listing |
The current state of mental health treatment for individuals diagnosed with major depressive disorder leaves billions of individuals with first-line therapies that are ineffective or burdened with undesirable side effects. One major obstacle is that distinct pathologies may currently be diagnosed as the same disease and prescribed the same treatments. The key to developing antidepressants with ubiquitous efficacy is to first identify a strategy to differentiate between heterogeneous conditions.
View Article and Find Full Text PDFJ Exp Psychol Hum Percept Perform
January 2025
Faculty of Psychology, University of Warsaw.
When we assess unknown people, we tend to be positively biased: we give them rather good assessments. However, can this positivity bias be limited or moderated? How would emotions of different origins (i.e.
View Article and Find Full Text PDFOpen Forum Infect Dis
January 2025
Vaccines, Pfizer Inc, Collegeville, Pennsylvania, USA.
Background: Serotype-specific urinary antigen detection (UAD) assay results can be used to estimate the serotype contribution among adults with pneumococcal community-acquired pneumonia (CAP) and to guide recommendations regarding higher-valency pneumococcal conjugate vaccines (PCVs).
Methods: Adults aged ≥18 years hospitalized with radiographic evidence of CAP were prospectively enrolled in 4 US cities from November 2019 to December 2020, overlapping the coronavirus disease 2019 (COVID-19) pandemic. Data were collected by patient interview and medical chart review.
J Phys Chem Lett
January 2025
State Key Laboratory of Superhard Materials, Key Laboratory of Material Simulation Methods & Software of Ministry of Education, and Jilin Provincial International Cooperation Key Laboratory of High-Efficiency Clean Energy Materials, Jilin University, Changchun 130012, China.
The multicentered bonds present in planar borophene lead to a more complex structure and richer chemical properties. Herein, we use first-principles calculations to investigate the electronic, mechanical, and superconducting properties of various borophene polymorphs, focusing on the newly synthesized β and β phases. Notably, in order to balance and optimize the electron filling of the valence bond orbitals, the planar borophene structure is composed of a mixture of triangular lattices and hexagonal holes with multicentered bonding, which further enhances the stability of the structure and possesses a rare polymorphic property.
View Article and Find Full Text PDFCogn Neurodyn
December 2025
International research center for Cognitive Applied Neuroscience (IrcCAN), Università Cattolica del Sacro Cuore, Milan, Italy.
The metacognition of one's planning strategy constitutes a "second-level" of metacognition that goes beyond the knowledge and monitoring of one's cognition and refers to the ability to use awareness mechanisms to regulate execution of present or future actions effectively. This study investigated the relation between metacognition of one's planning strategy and the behavioral and electrophysiological (EEG) correlates that support strategic planning abilities during performance in a complex decision-making task. Moreover, a possible link between task execution, metacognition, and individual differences (i.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!